Role of Molecular Markers (P53, EGFR AND VEGF) in Prognostication of Carcinoma Rectum

Journal of Medical Science And clinical Research
doi 10.18535/jmscr/v6i8.02
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Valley International

Related search

Carcinoma of the Rectum in Sisters

BMJ
1946English

DNA Markers in Molecular Diagnostics for Hepatocellular Carcinoma

Expert Review of Molecular Diagnostics
Forensic MedicineGeneticsPathologyMolecular MedicineMolecular Biology
2014English

Dual EGFR and mTOR Targeting in Squamous Cell Carcinoma Models, and Development of Early Markers of Efficacy

British Journal of Cancer
Cancer ResearchOncology
2007English

Operability of Carcinoma of Rectum: Corrigendum

BMJ
1941English

Mutations in P53 as Potential Molecular Markers for Human Breast Cancer.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1991English

Identification and Analysis of in Vivo VEGF Downstream Markers Link VEGF Pathway Activity With Efficacy of Anti-Vegf Therapies

Clinical Cancer Research
Cancer ResearchOncology
2013English

The Role of P53 Inactivation in Human Cervical Cell Carcinoma Development

British Journal of Cancer
Cancer ResearchOncology
1995English

Role of Inflammatory Markers in Prognosis of Oral Squamous Cell Carcinoma

Asian Pacific Journal of Cancer Prevention
2019English

Role of VEGF in Organogenesis

Organogenesis
Developmental BiologyEmbryologyBiomedical EngineeringTransplantation
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy